The impact of HCV eradication using interferon-free direct acting antivirals on bone-mineral, anemia parameters and peripheral insulin resistance in hepatitis c-infected Egyptian hemodialysis cohort

Table 5 Results of multiple regression analyses of PTH and FGF23 changes after SVR

Coefficients^a
Model	Unstandardized coefficients		Standardized coefficients	t	Sig	95% confidence interval for B
Model	B	Std. error	Beta	t	Sig	Lower bound	Upper bound
(Constant)	69.860	126.407	–	0.553	0.581	− 178.807	318.527
Ca (after 6 m)	12.052	33.305	0.050	0.362	0.718	− 53.465	77.569
PO4 (after 6 m)	48.569	41.750	0.216	1.163	0.246	− 33.561	130.699
Ca (after 12 m)	9.923	30.631	0.044	0.324	0.746	− 50.335	70.181
PO4 (after 12 m)	− 30.774	40.105	− .0142	− .767	0.443	− 109.668	48.120

Coefficients^b
Model	Unstandardized coefficients		Standardized coefficients	t	Sig	95% confidence interval for B
Model	B	Std. error	Beta	t	Sig	Lower bound	Upper bound
(Constant)	242.980	34.475	–	7.048	0.000	175.161	310.799
Ca (after 12 ms)	− 1.480	3.511	− 0.023	− 0.422	0.674	− 8.387	5.426
PO4 (after 12 ms)	1.706	3.392	0.028	0.503	0.615	− 4.967	8.379
PTH (after 12 ms)	− 0 .010	0.016	− 0.034	− 0.605	0.545	− 0.040	0.021

PO4 = serum phosphorus; Ca = serum Calcium; PTH = serum parathyroid hormone; FGF23 = Fibroblast growth factor 23, SVR: Sustained virological response
^aDependent variable: PTH_After 6 and 12 months
^bDependent variable: FGF23 changes after_12 months

ISSN: 2059-1381